EDGAR Filing Documents for 0001193125-19-245486

Form 8-K - Current report:

SEC Accession No. 0001193125-19-245486

Filing Date

2019-09-16

Accepted

2019-09-16 09:25:15

Documents

Period of Report

2019-09-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d803223d8k.htm iXBRL	8-K	70346
2	EX-2.1	d803223dex21.htm	EX-2.1	601907
3	EX-3.1	d803223dex31.htm	EX-3.1	4399
4	EX-99.1	d803223dex991.htm	EX-99.1	138030
5	EX-99.2	d803223dex992.htm	EX-99.2	76682
9	GRAPHIC	g803223dsp001a.jpg	GRAPHIC	3225
10	GRAPHIC	g803223dsp001b.jpg	GRAPHIC	2858
	Complete submission text file	0001193125-19-245486.txt		1232702

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	aldr-20190915.xsd	EX-101.SCH	3069
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	aldr-20190915_lab.xml	EX-101.LAB	17373
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	aldr-20190915_pre.xml	EX-101.PRE	10952
16	EXTRACTED XBRL INSTANCE DOCUMENT	d803223d8k_htm.xml	XML	3357

Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011

Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900

ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)